In the BioHarmony Drug Report Database

"Preview" Icon

Capecitabine

Xeloda (capecitabine) is a small molecule pharmaceutical. Capecitabine was first approved as Xeloda on 1998-04-30. It is used to treat breast neoplasms and colorectal neoplasms in the USA. It has been approved in Europe to treat breast neoplasms, colonic neoplasms, colorectal neoplasms, and stomach neoplasms. The pharmaceutical is active against thymidylate synthase.

 

Trade Name

 

Xeloda
 

Common Name

 

capecitabine
 

ChEMBL ID

 

CHEMBL1773
 

Indication

 

breast neoplasms, colonic neoplasms, colorectal neoplasms, stomach neoplasms
 

Drug Class

 

Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives

Image (chem structure or protein)

Capecitabine structure rendering